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Aim: Traumatic events are involved in the development and maintenance of psychotic symptoms. 
There are few trials exploring trauma-focused treatments as interventions for psychotic symptoms, 
especially in individuals with early psychosis. This trial will evaluate the feasibility and acceptability 
of conducting a definitive trial of Eye Movement Desensitisation and Reprocessing for psychosis 
(EMDRp) in people with early psychosis. 
Methods: 60 participants with first episode psychosis and a history of a traumatic/adverse life 
event(s) will be recruited from early intervention services in the North West of England and 
randomised to receive 16 sessions of EMDRp + Treatment as Usual (TAU) or TAU alone. Participants 
will be assessed at baseline, 6 months and 12 months post-randomisation using several measures of 
psychotic symptoms, trauma symptoms, anxiety, depression, functioning, service-user defined 
recovery, health economics indicators and quality of life. Two nested qualitative studies to assess 
participant feedback of therapy and views of professional stakeholders on the implementation of 
EMDRp into services will also be conducted. The feasibility of a future definitive efficacy and cost-
effectiveness evaluation of EMDRp will be tested against several outcomes, including ability to 
recruit and randomise participants, trial retention at 6- and 12-month follow-up assessments, 
treatment engagement and treatment fidelity. 
Conclusions: If it is feasible to deliver a multi-site trial of this intervention, it will be possible to 
evaluate whether EMDRp represents a beneficial treatment to augment existing evidence-based 
care of individuals with early psychosis supported by early intervention services.   
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Psychotic disorders are a major cause of personal and societal burden affecting approximately 0.7% 
of the population (McManus, Bebbington, Jenkins & Brugha, 2016). They are associated with long-
term disability (Wiersma et al., 2000), heightened mortality and risk of suicide (Palmer, Pankratz, & 
Bostwick, 2005; Saha, Chant, & McGrath, 2007) and reduced recovery outcomes (Jääskeläinen et al., 
2013). Recommended pharmacological and psychological interventions (NICE, 2014) can be 
effective, but response to treatment is modest and variable (e.g. Jauhar et al., 2014; Wykes, Steel, 
Everritt, & Tarrier, 2008). In addition, patients prescribed antipsychotic medications have relatively  
low rates of adherence, with approximately only two thirds of medication prescribed actually being 
taken (Cramer & Rosenheck, 2006). This may be due at least in part to marked and diverse profile of 
severe side effects (Young et al, 2015).  Cognitive Behaviour Therapy has consistent but small to 
moderate effects on positive symptoms only (Bighelli et al., 2018; McKenna et al., 2019).   Therefore, 
further work is required in order to improve outcomes.  
 
Approximately 80% of patients with psychosis have a history of traumatic life experiences (de Bont 
el al., 2015; Hardy et al., 2016). Meta-analyses indicate that trauma is associated with an increased 
risk of developing psychosis, and heightened severity of psychotic symptoms in those who already 
have psychosis (e.g. Beards et al., 2013; Varese, Smeets, et al., 2012). The prevalence of trauma and 
post-traumatic symptoms is particularly  marked in individuals with early psychosis (e.g. Rodrigues & 
Anderson, 2017), possibly due to additional traumatogenic experiences that many people with 
psychosis are exposed to in the early stages of the illness (e.g. coerced treatment, loss of 
employment and relationships, the experience of terrifying symptoms). In addition, a range of 
trauma sequalae, such as dissociation and intrusive memories/flashbacks, are involved in the 
maintenance of psychotic symptoms (Hardy et al., 2016; Varese, Barkus, & Bentall, 2012; Williams, 
Bucci, Berry, & Varese, 2018). Clinical guidelines (e.g. NICE, 2014) have recognised both the need for 
routine trauma assessment in people with first episode psychosis as well as the need for further 
evaluation of the efficacy and acceptability of trauma-focused therapies for this group.  




The treatment of trauma in people with psychosis has largely been ignored until recent years. 
Psychotic symptoms have been used as an exclusion criterion in 93% of existing trauma-focused 
intervention trials (Meyer, Farrell, Kemp, Blakey, & Deacon, 2014; Ronconi, Shiner, & Watts, 2014), 
despite the fact that that a substantial minority of patients with psychosis also meet the criteria for 
Post-Traumatic Stress Disorder (PTSD) and many more report subsyndromal, but nonetheless 
distressing, trauma symptoms (de Bont et al., 2015). Because of this, there has been recent interest 
in evaluating trauma-focused therapies in this patient group. Eye Movement Desensitisation and 
Reprocessing (EMDR) is, alongside Trauma-Focused Cognitive Behavioural Therapy (TF-CBT), one of 
the trauma-focused therapies that has received extensive empirical scrutiny in the last three 
decades (Bisson et al., 2007; Bisson, Roberts, Cooper, & Lewis, 2013). EMDR is endorsed as a 
recommended intervention for PTSD in several clinical guidelines worldwide (e.g. ISTSS, 2019; NICE, 
2018; World Health Organization, 2013) and recent health economic evaluations have attested to its 
cost-effectiveness relative to other trauma-focused approaches (Mavranezouli et al., 2020). Trials 
investigating the efficacy of EMDR and other trauma-focused therapies in people with severe mental 
illness and PTSD have been encouraging (Sin, Spain, Furuta, Murrells & Norman, 2017). A large-scale 
RCT in the Netherlands compared the efficacy of EMDR, prolonged exposure (PE) and treatment as 
usual in individuals with psychosis and comorbid PTSD. Patients receiving PE (56.6%; p=.006) or 
EMDR (60.0%; p<.001) were more likely to achieve loss of PTSD diagnosis compared to TAU (27.7%; 
van den Berg et al., 2015). Both treatments were safe and acceptable, and gains were maintained at 
6 months. Secondary analyses indicated that there were significant reductions in symptoms of 
psychosis in people who received these interventions (de Bont et al., 2016) but conclusions drawn 
are limited as the trials were not designed to assess change in psychotic symptoms.  
 
Whilst EMDR is already being successfully adapted to treat mental health difficulties other than PTSD 
in people with a trauma history (Novo et al., 2014; Wood & Ricketts, 2013), previous psychosis trials 
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have exclusively evaluated EMDR as a treatment for comorbid PTSD in people with long-standing 
psychotic disorders. The current trial addresses priorities identified by previous systematic reviews 
on the application of trauma-focused therapy in people with psychosis (Sin & Spain, 2017; Sin et al., 
2017; Swan, Keen, Reynolds, & Onwumere, 2017), in particular 1) whether EMDR can be used safely 
and effectively in patients with recent onset psychosis and patients with trauma symptoms that do 
not necessarily meet diagnostic thresholds for PTSD, and 2) whether EMDR can be used to directly 
ameliorate symptoms of psychosis. Our intervention was adapted from previous work (van den Berg, 
van der Vleugel, Staring, de Bont, & de Jongh, 2013,) and consists of a 16-session manualised EMDR 
intervention specifically modified to target distressing psychotic symptoms in out-patients with early 
psychosis. The intervention was developed from pilot work with first episode psychosis clients 
indicating clinically significant improvements in psychotic symptoms, trauma-related symptoms, 
anxiety and depression (Ward-Brown et al, 2018). Participants experienced therapy as highly 
acceptable and helpful, their feedback being used to refine the approach further. The present 
investigation will examine whether it is feasible to conduct a larger-scale evaluation of “EMDR for 
psychosis” (EMDRp).  The results of this work will be used to inform the design of the future trial, 
including necessary sample size calculations for a definitive efficacy and cost-effectiveness 
assessment. It is anticipated that the future trial would focus on the reduction of psychotic 
symptoms as a primary outcome, with secondary outcomes including trauma symptoms. However, 
in order to ensure feasibility, a preliminary trail is required before engaging in the large-scale 
programme.   
 
Aims 
To evaluate the feasibility and acceptability of conducting a definitive trial of EMDRp in people with 
early psychosis. Feasibility will be ascertained across a range of critical parameters, including: 
recruitment and randomisation rate, therapy engagement, assessment retention and therapy fidelity 
(see Table 1). Acceptability will be ascertained by qualitative investigations with professionals and 
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service-user participants who have received the EMDRp therapy intervention. Examination of the 
completeness of outcome measures and variance in outcomes will be used to inform the design and 
power calculation of a future definitive trial. 
 




The EASE trial (“Eye movement desensitization and reprocessing therapy in early psychosis: A 
feasibility randomised controlled trial”, ISRCTN16262847) is a single-blind, parallel group 
randomised controlled trial with random allocation to one of two arms; EMDRp alongside TAU 
versus TAU alone. Allocation will be assigned at a ratio of 1:1 and will be concealed from the 
assessing research assistants (RAs). Participants in both arms will complete assessments at baseline, 
6 months and 12 months post-randomisation. Two qualitative studies will be nested within the trial, 
one exploring the service user participants’ views concerning acceptability and impact of the 
intervention, and the other exploring the views of professionals regarding implementation of 
EMDRp within services. 
 
Participants 
The trial will comprise of 60 individuals with first episode psychosis and a history of trauma. 
Inclusion criteria are listed in Table 2. 
 
TABLE 2 ABOUT HERE 
 
The recruitment target was informed by feasibility trials guidelines (Arain, Campbell, Cooper, & 
Lancaster, 2014; Eldridge, Lancaster, et al., 2016; Lancaster, Dodd, & Williamson, 2004) and will 
EMDR for Early Psychosis 
7 
 
enable the estimation of recruitment and retention parameters as well as the variance of outcome 
measures.  Recruitment will take place across Early Intervention (EI) teams in the North West of 
England. The trial will be introduced to potential participants by their usual care team; informed 
consent will be obtained by trained research assistants (RAs) prior to confirming eligibility via the 
Trauma Screening Questionnaire and the Positive and Negative Syndrome Scale (Table 2).  
 
Randomisation 
Participants will be randomly allocated (1:1 ratio) to either EMDRp + TAU, or TAU alone by an 
unblinded member of the research team (the principal investigator, the trial manager or the trial 
statistician) using an online pseudo-random list with random permuted blocks of varying sizes. 
Allocation will be concealed from the RAs conducting assessments. 
 
Intervention 
EMDR is a trauma-focused therapy in which memories of traumatic experiences are reprocessed to 
decrease the distress caused by them and change the dysfunctional beliefs and perceptual 
associations related to the traumatic event. This is achieved through an eight-phase treatment 
protocol addressing past memories, present triggers and future templates. Treatment phases are 
outlined in Table 3. Phases do not correspond to specific therapy sessions; multiple phases (usually 
phases 3-7) can be executed sequentially within the same session. Typically, an EMDR session lasts 
from 60 to 90 minutes with treatment generally lasting between 8 and 12 sessions. However, more 
sessions are recommended in the context of complex mental health presentations and 
severe/multiple trauma histories (NICE, 2018). 
 
TABLE 3 ABOUT HERE  
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The intervention offered in the current trial will be entirely consistent with the 8 phases of the 
standard EMDR protocol but the focus of certain EMDR phases, most notably  have been modified 
and expanded. This accounts for specific issues related to the experience of psychotic symptoms and 
their impact on the client’s well-being. The treatment protocol builds on specific adaptations already 
suggested in the application of EMDR to the treatment of psychosis (e.g. van den Berg et al. 2013), 
but represents the first attempt to deliver a manualised intervention that systematically implements 
these psychosis-specific adaptations. These adaptations involve the inclusion of:  
a) a more explicit focus on structure and containment within sessions to safely adhere to the 
limit of up to 16 sessions provided. This is achieved through maintaining a clear strand of 
goal-orientated focus throughout therapy, centring on clients’ most distressing present-day 
challenge(s) and linking this back to and working through related distressing/traumatic 
experience(s), to help progress towards achieving chosen therapeutic goal(s); 
b) An enhanced focus on psychoeducation, grounding and client preparation techniques - 
designed to enable successful reprocessing of traumatic memories including those 
associated with dissociation (a common concomitant of psychotic experiences; Pilton, 
Varese, Berry, & Bucci, 2015), concurrent acute psychotic symptoms and related difficulties 
(e.g. inattention). This may include an enhanced preparation phase, using tools such as the 
Constant Installation of POS (and enhanced practice of EMDR-related resource building and 
visualisation exercises, with a specific focus on psychosis-related challenges or barriers in 
therapy (such as paranoia, hearing voices etc.).   
c) assessment and therapeutic work around trauma symptoms that may not reach diagnostic 
threshold for PTSD, to familiarise participants with the EMDR approach before targeting 
more complex trauma memories or psychosis-related traumatic experiences;  
d) traumatic experiences that preceded or precipitated the onset of illness (and which may be 
thematically linked to psychotic symptoms; e.g. Hardy et al., 2005),  
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e) the traumatic impact of the psychotic episode itself (a source of considerable traumatic 
stress in many first episode psychosis patients; Berry, Ford, Jellicoe-Jones, & Haddock, 2013; 
Wilson, Becker, & Tinker, 1997);  
f) the impact of adverse life experiences and circumstances that might have exacerbated 
maladaptive appraisals about psychotic experiences as well as negative beliefs about the self 
and others that are common in people with psychosis and are associated with distress and 
impairment in this client group (Garety, Kuipers, Fowler, Freeman, & Bebbington, 2001; 
Morrison, 2001);  
 
The treatment will be delivered by EMDR therapists who have experience in working with people 
with psychosis and/or PTSD. All therapists will receive an initial 3-day training workshop in our 
EMDRp protocol and will attend fortnightly group supervision sessions.  
 
Treatment fidelity 
Using the Modified EMDR Fidelity Checklist (Cooper et al. 2019) an EMDR consultant will rate a 
random selection of therapy recordings (3-5 sessions per therapist) to ensure adherence to EMDR 
when delivering our protocol.  After each therapy session, therapists will also complete a 
standardised session record form to monitor session content; these will be reviewed during monthly 
supervision meetings to maximise treatment fidelity throughout the trial.    
 
Comparator 
TAU will be in line with all standard and individually prescribed clinical interventions as directed by 
clinical guidelines for psychosis (NICE, 2014) and the participants’ clinical team, and may include 
antipsychotic medications and/or psychological interventions. Although EMDR is not routinely 
employed in the treatment of psychosis, TAU participants with comorbid PTSD may be referred by 
their clinical teams to other services to receive a trauma-focused interventions (TF-CBT or EMDR). 
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For ethical reasons, the care teams will not be asked to withhold such referrals/interventions. 
Instead, the care received by TAU participants will be monitored carefully through case notes 
reviews after the 12-month assessment. 
 
Outcomes 
This trial is designed to evaluate the feasibility of conducting a future definitive trial. Therefore the 
data collected at baseline and follow-up assessments are intended to evaluate the feasibility of 
completing the battery of measures to be employed in the future trial. At both baseline and follow-
up assessments, we will administer several measures assessing psychotic symptoms, trauma 
symptoms, anxiety, depression, functioning, service-user defined recovery as well as quality of life 
and service usage data to inform future heath economics analyses (Table 4). 
 
TABLE 4 ABOUT HERE 
 
Analysis 
Descriptive statistics will be used to summarise assessments of feasibility and acceptability in terms 
of the primary outcomes (Table 1). Further descriptive information on the flow of participants across 
the trial will be provided in accordance with relevant CONSORT fields for feasibility trials (Eldridge, 
Chan, et al., 2016). These will include: 1) number of referrals received per month, 2) source of 
recruitment, 3) number of participants contacted, 4) number of participants assessed for eligibility, 
5) number of participants consented into the trial and randomised, 6) reasons for non-eligibility or 
withdrawal of interest, 7) retention of participants between baseline, end-of-treatment and follow-
up assessment periods, discriminating between participants who did not receive the treatment 
allocated and individuals lost to follow-up, 8) all important harms or unintended effects and 9) the 
completeness of participant’s responses on all self-reports. Data on all self-report and researcher-
administered outcome measures will be examined for completeness. No formal hypothesis testing 
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will be carried out comparing the two groups for clinical effectiveness. However, outcome measures 
will be summarised by arm and standard deviations will be estimated to inform the design of a 
future trial. Estimation of the integrity of the intervention will rely on descriptive analyses of the 
EMDR fidelity checklists and data from therapy session record forms. This will inform training and 
supervision provision of the future definitive trial.  
 
Qualitative studies 
One month following their 6-month post-randomisation (end of treatment) assessment, participants 
in the EMDRp + TAU arm will be invited to complete a qualitative interview. Consistent with previous 
work (Awenat, Shaw-Núñez et al. 2017), we will use purposive sampling to recruit a wide range of 
participants, based upon demographics and therapy experiences (e.g. by recruiting participants with 
poor vs good treatment response). Semi-structured interviews conducted a researcher unblinded to 
treatment allocation will be audio-recorded and transcribed. Inductive Thematic Analysis (Clarke & 
Braun, 2013) will be used to extract themes relating to experiences of participating in the trial and 
undergoing EMDRp.  
 
Also consistent with previous work (Awenat, Peters, Shaw-Nunez, Gooding, Pratt & Haddock, 2017), 
We will also recruit approximately 20 professionals (dependent upon theoretical sufficiency) whose 
role would impact either on participant referral to the trial (‘gatekeepers’) and the commissioning, 
service/treatment delivery and/or management of psychological therapies for psychosis. Purposive 
sampling will facilitate recruitment of wide range of professional backgrounds from across 
healthcare organisations and relevant services (e.g. commissioners; therapy services managers; EI 
care co-ordinators, clinical psychologists and psychiatrists). These interviews will cover questions 
relevant to the future implementation of EMDRp, including their stakeholders’ views on their 
understanding, views and concerns about EMDR and the perceived barriers to implementing EMDRp 
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in EI services, alongside solutions to such barriers/problems.  All interviews will be audio recorded, 
transcribed verbatim and analysed using inductive thematic analysis.  
 
Discussion 
The impact of trauma and the management of trauma-related symptoms in people with psychosis is 
a recognised research priority (NICE, 2014). The overarching aim is to determine the feasibility of 
running a definitive trial of EMDRp within EI services. The delivery of such trials is vital to improving 
outcomes for those affected by early psychosis and trauma. The application of trauma-focused 
therapies to the treatment of psychosis is in its infancy. However, based on extensive evidence 
linking trauma sequelae to psychotic symptoms (Williams et al., 2018), it is possible that EMDRp may 
have direct effects on psychotic symptoms. Our feasibility data will allow evaluation of the likely 
levels of recruitment and retention into a future larger-scale trial. The project will also enable the 
evaluation of the acceptability of EMDRp by considering levels of therapy engagement, the 
qualitative feedback from participants allocated to receive EMDRp, and the extent to which EMDR 
therapists can deliver our EMDRp protocol with high level of fidelity.  
 
Several trials have recently been conducted to evaluate the efficacy of trauma-focused therapy in 
people with psychotic disorders (e.g. Brand et al. 2018). The present trial is distinguished in that the 
primary focus is the evaluation of a treatment protocol aimed at improving psychotic symptoms 
rather than co-morbid PTSD. Furthermore, whilst previous trials have predominantly focused on 
participants who have been living with psychosis for many years (e.g. van den Berg et al. 2015), our 
trial specifically considers individuals with early psychosis who receive support from EI services. 
Access to effective treatment in the first few years following the onset of psychosis is a crucial 
determinant of future clinical and functional outcomes (Bird et al., 2010). The findings of our trial 
and the future definitive evaluation informed by the present trial will confirm whether trauma-
focused therapies could augment existing evidence-based treatment options for early psychosis, and 
EMDR for Early Psychosis 
13 
 
should therefore be offered routinely to clients supported by EI services. Our EMDRp intervention 
was developed from previous clinical recommendations for adapting the delivery of EMDR to people 
with distressing psychosis (van der Berg et al., 2013) and with input from ‘experts-by-experience’ 
who took part in case studies of trauma-focused therapy in early psychosis conducted by members 
of our team (Ward-Brown et al 2018; Ward-Brown & Keane, 2019). A further strength is that the 
design of the trial has been developed in collaboration between academic researchers, frontline 
trauma therapists and experts-by-experience, hopefully ensuring the development of a “real-world”, 
practical and effective intervention which improves outcomes for those affected by psychosis and 
experiences of trauma and could be implemented in future clinical practice in a sustainable and 
effective way.  
 
There are several limitations to the study. First, our feasibility trial does not have an active control 
treatment arm, so our findings will be silent regarding the potential effectiveness of EMDRp relative 
to other psychosocial interventions with an established evidence-base for the treatment of 
psychosis, or other trauma-focused therapies. Second, this early stage evaluation is unlikely to shed 
light on the mechanisms of action of EMDR when applied to the treatment of trauma-related 
difficulties reported by people with psychosis. Both limitations could be addressed in the future 
definitive trial through the selection of evidence-based psychosocial comparators (e.g. Cognitive 
Behavioural Therapy for psychosis; NICE, 2014) and the integration of research methods to evaluate 
mechanisms of efficacy of complex mental health interventions (e.g. Dunn et al 2015), a line of 
research that could be informed by the growing evidence on the potential mediators of the trauma-
psychosis relationship (Williams et al., 2018) and the neural and psychological mechanisms of action 
of EMDR in other patient groups (e.g. Landin-Romero et al., 2018). 
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Table 1:  Feasibility outcomes of the EASE trial 
 
Criterion Critical feasibility  
outcome 
Other feasibility and 
acceptability data  
relevant to the criterion  
 







• Number of 
participants 
consented into the 
trial and randomised 
 
 
• Number of referrals 
per month  
• Source of 
recruitment 
• Number of 
participants 
contacted, 
• number of 
participants assessed 
for eligibility 





  Feasibility will be demonstrated where an 
average of at least 3 participants are 
recruited and randomised per month 
 
 
If at least 2 participants are recruited per 
month, then a future trial will be feasible 
but additional strategies must be identified 
to support recruitment (e.g. informed by 
other feasibility data relevant to this 
criterion) 
 
If an average of 1 participant is recruited 
per month over the recruitment period 
(<20 participants), feasibility within the 





• % who drop-out of 
therapy / % who did 
not receive treatment 
allocated 
 
• Session record forms 
for each therapy 
session 
• Number of therapy 
sessions attended 
 Feasibility will be demonstrated if at least 
70% of the participants in the intervention 
arm completed at least 8 out of the 16 
sessions of EMDRp 
 
 




interviews with SU 
participants 
 
If 50-70% of participants in the 
intervention arm complete at least 8 out of 
the 16 sessions of EMDRp 
 
If less than 50% of participants in the 
intervention arm complete at least 8 out of 




• % of participants 
who are lost to 
follow-up at end-of-
treatment and follow-
up assessment points 
• Reasons for 
withdrawal from the 
study 
• Qualitative 
interviews with SU 
participants 
 
 If at least 70% of participants are retained 
and the end-of-treatment and follow-up 
assessments, feasibility will be 
demonstrated 
 
If 30-70% of participants are retained at 
the end-of-treatment and follow-up 
assessments, a future trial will be feasible 
if strategies to overcome barriers are 
identified (e.g. via other data relevant to 
this criterion) 
 
If less than 30% of participants are 
retained at the end-of-treatment and 
follow-up assessments, feasibility within 






• Adherence ratings 
from therapy tapes 
• Session record form 
for each therapy 
session (including 
 Feasibility will be demonstrated if over 
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reasons for deviation 
from protocol)  
If 50-80% of rated therapy tapes will be 
rated as acceptable, a future trial will be 
feasible if strategies to overcome 
identified barriers (e.g. exploring the 
reasons for deviation from protocol 
recorded in the therapist checklists) 
 
If less than 50% of rated therapy tapes 
will be rates as acceptable, feasibility 





Note. Key:  Green = Continue to main study without modifications - feasible as it is; Amber = Continue but modify protocol – the 
future definitive trial is feasible with modifications. Red = Stop – future definitive trial is not feasible.  
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Table 2 - Participant inclusion and exclusion criteria 
Inclusion 
Criteria: 
1. Aged at least 16 years 
2. Capacity and willingness to provide informed consent 
3. a. ICD diagnosis of schizophrenia-spectrum disorders (ICD codes F20, F22, F23, F25, F28, F29; ICD-11 codes 6A20, 6A21, 6A23, 6A24, 
6A2Y,6A2Z)  
b. or criterion level of positive symptoms severity, indicated by a score > 3 (symptom present) on the delusions (P1), hallucinations 
(P3), grandiosity (P5) or suspiciousness (P6) items of the PANSS in the previous week;  
c. and/or the psychosis transition criteria of the CAARMS  
4. In contact with mental health services, and have an assigned care-coordinator; 
5. Within 3 years from psychosis onset 
6. Judged by the assigned care-coordinator/responsible clinician as clinically stable (no treatment change in the previous month, not 
acutely suicidal and no suicide attempt in the previous two months) 
7. Reporting at least 1 traumatic event on the TSQ, and at least subsyndromal post-traumatic symptoms in the previous week (scores > 
0 on items 3_1 to 3_5 of the TSQ) 
Exclusion 
Criteria: 
1. Primary diagnosis of substance/alcohol dependence, intellectual disability or cognitive dysfunction, as provided by the participant 
care-coordinator/clinical team 
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2. Non-English speaking or requiring an interpreter for the intervention (the therapy and assessment battery at present can only be 
delivered in English) 
3. Receipt of EMDR from a qualified psychological therapist in accordance with NICE guidelines for PTSD (National Institute for Health 
and Clinical Excellence, 2018) in the past 12 months 
Note. Key: CAARMS = Comprehensive Assessment of At-Risk Mental States (Yung et al., 2005); EMDR = Eye Movement Desensitisation and Reprocessing 
Therapy; ICD = the International Classification of Disease; PANSS = Positive and Negative Syndrome Scale (Kay, Fiszbein, & Opler, 1987); TSQ = Trauma 
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Table 3 - Standard EMDR treatment protocol phases (Shapiro, 2001) 
Phase Details of EMDR protocol 
1 History Taking (including discussion of the rationale for therapy and case conceptualisation/idiographic formulation of the client’s difficulties) 
2 Preparation (preparation for reprocessing of target trauma memories and equipping clients with strategies to better self-regulate during trauma 
reprocessing work) 
3 Assessment (the identification of a specific target memory/image as well as associated negative cognitions, disturbing emotions or bodily 
sensations; a positive cognition that is preferable to the negative one is also identified) 
4 Desensitisation and Reprocessing (involving the repetitive use of bilateral stimulation e.g. the tracking of a moving object, whilst the client is 
asked to simultaneously focus on  the image, the negative cognition, and the disturbing emotion or body sensation until he/she reports a 
marked reduction in distress associated with these experiences) 
5 Installation (in which the client is encouraged to associate the trauma memory with the positive cognition previously identified, or a new more 
adaptive positive cognition) 
6 Body scan (designed to target any residual negative/uncomfortable physical sensation or bodily tension associated with the trauma memory) 
7 Closure (generally involving the use of distress management and tolerance strategies before the end of the session) 
8 Re-evaluation (where the client and therapist re-assess the previous target to evaluate whether additional work is necessary before proceeding 
further with the intervention)  
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Table 4 - Summary of measures used to assess participant symptoms across three time points 
Demographic Information: Baseline 6-months 12-months 
Age, sex, ethnicity, employment status and occupation (if relevant), marital status, education level, self-
reported diagnosis, time since first episode of psychosis, duration of Early Intervention service input, 
number and reasons for past psychiatric hospitalisations, current prescribed medications for mental health 
difficulties (including dosage), diagnosis. 
X Updated as required 
Psychosis-related measures: Baseline 6-months 12-months 
PANSS  The most widely-used research measure to assess the severity of positive and negative 
symptoms of psychosis as well as symptoms of general psychopathology. 
X X X 
PSYRATS  A semi-structured interview completed alongside the PANSS to provide a more fine-
grained assessment of auditory hallucinations and delusions, including measures of 
subjective distress caused by these symptoms 
X X X 
GPTS A brief self-report questionnaire assessing paranoid thinking and persecutory delusions.    X X X 
VIS  A questionnaire assessing a range of positive and negative consequences of voices (i.e. 
auditory verbal hallucinations) on various domains 
X X X 
QPR  A service user-defined measure of subjective recovery from psychosis. X X X 
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Trauma-related measures: Baseline 6-months 12-months 
 TSQ  A brief measure used to screen for trauma exposure and post-traumatic stress symptoms. 
In the present study, the modified version of the TSQ developed by de Bont et al (2015) for 
use in people with psychosis will be used to check the participants’ potential eligibility in 
this trial 
X   
 TALE  A measure specifically designed to assess exposure to adverse and traumatic life 
experiences that are commonly reported by people with psychosis.  
X   
 PCL-5  A self-report questionnaire assessing the presence and severity of post-traumatic 
symptoms.  
X X X 
 ITQ   A brief measure assessing the severity of symptoms of PTSD and complex PTSD as defined 
in the recently published ICD-11.   
X X X 
 DES-II  A self-report measure of dissociation. X X X 
Health economic measures: Baseline 6-months 12-months 
EQ-5D-5L  A health status questionnaires used in health economics analyses. X X X 
EPQ  An adapted version of the EPQ for specific use in early intervention for psychosis services. X X X 
Other mental health and functioning measures: 
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GAD-7  A brief and widely-used questionnaires assessing symptoms of anxiety.  X X X 
PHQ-9  A brief and widely-used questionnaires assessing symptoms of depression. X X X 
PSP  A scale assessing patients’ functioning in four areas (socially useful activities, personal and 
social relationships, self-care and disturbing/aggressive behaviours). 
X X X 
QPR  A service user-defined measure of subjective recovery from psychosis. X X X 
Note. Key: DES-II = The Dissociative Experiences Scale-II (Carlson & Putnam, 1993); EPQ = Economic Patient Questionnaire (Davies et al., 2007); EQ-5D-5L = The EuroQol 
5-Dimension 5-Level measure (Janssen et al., 2013); GAD-7 = The Generalized Anxiety Disorder Questionnaire (Spitzer, Kroenke, Williams, & Löwe, 2006); GPTS = Green 
Paranoid Thoughts Scale (Green et al., 2007); ITQ = International Trauma Questionnaire (Cloitre et al., 2018); PANSS = Positive and Negative Syndrome Scale (Kay, 
Fiszbein, & Opler, 1987); PCL-5 = The PTSD Checklist for DSM-5 (Blevins, Weathers, Davis, Witte, & Domino, 2015); PHQ-9 = The Patient Health Questionnaire (Kroenke, 
Spitzer, & Williams, 2001); PSP = The Personal and Social Performance Scale (Morosini, Magliano, Brambilla, Ugolini, & Piolo, 2000); PSYRATS = The Psychotic Symptoms 
Rating Scales (Haddock, McCarron, Tarrier, & Faragher, 1999); QPR = The Questionnaire about the Process of Recovery (Neil et al., 2009); TALE = The Trauma and Life 
Events checklist (Carr, Hardy, & Fornells-Ambrojo, 2018); TSQ = The Trauma Screening Questionnaire (de Bont et al., 2015); VIS =  The Voices Impact Scale (Strauss, n.d.)  
 
 
